Background: Individual amino acid residues of the major birch pollen allergen, Bet v 1, have been identified to be crucial for IgE recognition. The objective of the present study was to evaluate whether this concept was applicable for the Bet v 1-homologous apple allergen, Mal d 1. Methods: A Mal d 1 five-point mutant was produced by PCR techniques, cloned into pMW 172 and expressed in Escherichia coli BL21(DE3) cells. To evaluate the allergenic properties of the engineered protein compared to Mal d 1 wild-type IgE immunoblotting, ELISA, peripheral blood monocytes proliferation assays, and skin prick tests were performed. Results: The Mal d 1 mutant showed reduced capacity to bind specific IgE as compared to wild-ype Mal d 1 in in vitro assays in the majority of the sera tested. In ELISA, 10 out of 14 serum samples displayed an 88–30% decrease in IgE binding to Mal d 1 mutant compared to wild-type Mal d 1. Skin prick tests in apple-allergic patients (n = 2) confirmed the markedly decreased ability of the Mal d 1 mutant to induce allergic reactions in vivo. However, the relevant T cell epitopes were present in the mutated molecule according to peripheral blood mononuclear cell proliferation assays. Conclusions: Our findings suggest that it is possible to modulate the IgE-binding properties of allergens by single amino acid substitutions at crucial positions which might be useful for future immunotherapy of birch-pollen-associated food allergies which are not ameliorated by birch pollen immunotherapy.

1.
Eriksson NE, Formgren H, Svenonius E: Food hypersensitivity in patients with pollen allergy. Allergy 1982;37:437–443.
2.
Wuthrich B, Stager J, Johansson SG: Celery allergy associated with birch and mugwort pollinosis. Allergy 1990;45:566–571.
3.
van Ree R, Aalberse R: Pollen-vegetable food crossreactivity: serological and clinical relevance of crossreactive IgE. J Clin Immunoassay 1993;16:124–130.
4.
Ebner C, Hirschwehr R, Bauer L, Breiteneder H, Valenta R, Ebner H, Kraft D, Scheiner O: Identification of allergens in fruits and vegetables: IgE cross- reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995;95:962–969.
5.
Breiteneder H, Hoffmann-Sommergruber K, O’Riordain G, Susani M, Ahorn H, Ebner C, Kraft D, Scheiner O: Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17-kDa tree pollen allergens. Eur J Biochem 1995;233:484–489.
6.
Hoffmann-Sommergruber K, O’Riordain G, Ahorn H, Ebner C, Laimer-Da-Camara-Machado M, Puhringer H, Scheiner O, Breiteneder H: Molecular characterization of Dau c 1, the Bet v 1 homologous protein from carrot and its cross-reactivity with Bet v 1 and Api g 1. Clin Exp Allergy 1999;29:840–847.
7.
Vanek-Krebitz M, Hoffmann-Sommergruber K, Laimer da Camara Machado M, Susani M, Ebner C, Kraft D, Scheiner O, Breiteneder H: Cloning and sequencing of Mal d 1, the major allergen from apple (Malus domestica), and its immunological relationship to Bet v 1, the major birch pollen allergen. Biochem Biophys Res Commun 1995;214:538–551.
8.
Wensing M, Akkerdaas JH, van Leeuwen WA, Stapel SO, Bruijnzeel-Koomen CA, Aalberse RC, Bast BJ, Knulst AC, van Ree R: IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance. J Allergy Clin Immunol 2002;110:435–442.
9.
Vieths S, Schoning B: Characterization of Mal d 1, the 18-kD major apple allergen, at the molecular level. Monogr Allergy 1996;32:63–72.
10.
Fritsch R, Ebner C, Kraft D: Allergenic crossreactivities. Pollens and vegetable foods. Clin Rev Allergy Immunol 1997;15:397–404.
11.
Tuft L, Blumenstein G: Studies in food allergy. J Allergy 1942;13:574–581.
12.
Bjoerksten F, Halmepuro L, Hannuksela M, Lahti A: Extraction and properties of apple allergens. Allergy 1980;35:671–677.
13.
Asero R: Effects of birch pollen SIT on apple allergy: a matter of dosage? Allergy 2004;59:1269–1271.
14.
Bolhaar ST, Tiemessen MM, Zuidmeer L, van Leeuwen A, Hoffmann-Sommergruber K, Bruijnzeel-Koomen CA, Taams LS, Knol EF, van Hoffen E, van Ree R, Knulst AC: Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy 2004;34:761–769.
15.
Hansen KS, Khinchi MS, Skov PS, Bindslev-Jensen C, Poulsen LK, Malling HJ: Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutr Food Res 2004;48:441–448.
16.
Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, Klotz F, Ebner H, Kraft D, Scheiner O: Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin Exp Allergy 1997;27:1007–1015.
17.
Blaser K, Akdis CA: Interleukin-10, T regulatory cells and specific allergy treatment. Clin Exp Allergy 2004;34:328–331.
18.
Savolainen J, Laaksonen K, Rantio-Lehtimaki A, Terho EO: Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy 2004;34:413–419.
19.
Ferreira F, Ebner C, Kramer B, Casari G, Briza P, Kungl AJ, Grimm R, Jahn-Schmid B, Breiteneder H, Kraft D, Breitenbach M, Rheinberger HJ, Scheiner O: Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 1998;12:231–242.
20.
Wallner M, Gruber P, Radauer C, Maderegger B, Susani M, Hoffmann-Sommergruber K, Ferreira F: Lab scale and medium scale production of recombinant allergens in Escherichia coli. Methods 2004;32:219–226.
21.
Hoffmann-Sommergruber K, Susani M, Ferreira F, Jertschin P, Ahorn H, Steiner R, Kraft D, Scheiner O, Breiteneder H: High-level expression and purification of the major birch pollen allergen, Bet v 1. Protein Expr Purif 1997;9:33–39.
22.
Willerroider M, Fuchs H, Ballmer-Weber BK, Focke M, Susani M, Thalhamer J, Ferreira F, Wuthrich B, Scheiner O, Breiteneder H, Hoffmann-Sommergruber K: Cloning and molecular and immunological characterisation of two new food allergens, Cap a 2 and Lyc e 1, profilins from bell pepper (Capsicum annuum) and Tomato (Lycopersicon esculentum). Int Arch Allergy Immunol 2003;131:245–255.
23.
Guex N, Peitsch MC: Swiss-Model and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997;18:2714–2723.
24.
Himly M, Jahn-Schmid B, Dedic A, Kelemen P, Wopfner N, Altmann F, van Ree R, Briza P, Richter K, Ebner C, Ferreira F: Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. FASEB J 2003;17:106–108.
25.
Wopfner N, Willerroider M, Hebenstreit D, van Ree R, Aalbers M, Briza P, Thalhamer J, Ebner C, Richter K, Ferreira F: Molecular and immunological characterization of profilin from mugwort pollen. Biol Chem 2002;383:1779–1789.
26.
Dreborg S: Allergen standardisation and skin tests. EAACI position paper. Allergy 1993;48:49–82.
27.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970;227:680–685.
28.
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulse sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350–4354.
29.
Jarolim E, Rumpold H, Endler AT, Ebner H, Breitenbach M, Scheiner O, Kraft D: IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa. Allergy 1989;44:385–395.
30.
Dreborg S, Foucard T: Allergy to apple, carrot and potato in children with birch pollen allergy. Allergy 1983;38:167–172.
31.
Poulsen LK, Liisberg C, Bindslev-Jensen C, Malling H: Precise area determination of skin prick tests: validation of a scanning device and software for a personal computer. Clin Exp Allergy 1993;23:61–68.
32.
Bohle B, Radakovics A, Jahn-Schmid B, Hoffmann-Sommergruber K, Fischer GF, Ebner C: Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level. Eur J Immunol 2003;33:3303–3310.
33.
Hirel PH, Schmitter MJ, Dessen P, Fayat G, Blanquet S: Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc Natl Acad Sci USA 1989;86:8247–8251.
34.
Friedl-Hajek R, Radauer C, O’Riordain G, Hoffmann-Sommergruber K, Leberl K, Scheiner O, Breiteneder H: New Bet v 1 isoforms including a naturally occurring truncated form of the protein derived from Austrian birch pollen. Mol Immunol 1999;36:639–645.
35.
Hoffmann-Sommergruber K, Demoly P, Crameri R, Breiteneder H, Ebner C, Laimer-Da-Camara-Machado M, Blaser K, Ismail C, Scheiner O, Bousquet J, Menz G: IgE reactivity to Api g 1, a major celery allergen, in a Central European population is based on primary sensitization by Bet v 1. J Allergy Clin Immunol 1999;104:478–484.
36.
Hoffmann-Sommergruber K, Ferris R, Pec M, Radauer C, O’Riordain G, Laimer Da Camara Machado M, Scheiner O, Breiteneder H: Characterization of Api g 1.0201, a new member of the Api g 1 family of celery allergens. Int Arch Allergy Immunol 2000;122:115–123.
37.
Son DY, Scheurer S, Hoffmann A, Haustein D, Vieths S: Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen. Eur J Nutr 1999;38:201–215.
38.
Ferreira F, Hirtenlehner K, Briza P, Breiteneder H, Scheiner O, Kraft D, Breitenbach M, Ebner C: Isoforms of atopic allergens with reduced allergenicity but conserved T cell antigenicity: possible use for specific immunotherapy. Int Arch Allergy Immunol 1997;113:125–127.
39.
Kumar S, Tsai CJ, Nussinov R: Factors enhancing protein thermostability. Protein Eng 2000;13:179–191.
40.
Schindler T, Mayr LM, Landt O, Hahn U, Schmid FX: The role of a trans-proline in the folding mechanism of ribonuclease T1. Eur J Biochem 1996;241:516–524.
41.
Eyles SJ, Gierasch LM: Multiple roles of prolyl residues in structure and folding. J Mol Biol 2000;301:737–747.
42.
Puehringer HM, Zinoecker I, Marzban G, Katinger H, Laimer M: MdAP, a novel protein in apple, is associated with the major allergen Mal d 1. Gene 2003;321:173–183.
43.
Helsper JP, Gilissen LJ, van Ree R, America AH, Cordewener JH, Bosch D: Quadrupole time-of-flight mass spectrometry: a method to study the actual expression of allergen isoforms identified by PCR cloning. J. Allergy Clin Immunol 2002;110:131–138.
44.
Bolhaar STHP, Zuidmeer L, Ma Y, Ferreira F, Bruijnzeel-Koomen CAFM, Hoffmann-Sommergruber K, vanRee R, Knulst AC: A mutant of the major apple allergen, Mad d 1, demonstrating hypoallergenicity in the target organ by double-blind placebo-controlled food challenge. Clin Exp Allergy 2005; doi: 1111/j.1365.2222.2005.02390.x.
45.
Neudecker P, Schweimer K, Nerkamp J, Scheurer S, Vieths S, Sticht H, Rosch P: Allergic cross-reactivity made visible: solution structure of the major cherry allergen Pru av 1. J Biol Chem 2001;276:22756–22763.
46.
Neudecker P, Lehmann K, Nerkamp J, Haase T, Wangorsch A, Fotisch K, Hoffmann S, Rosch P, Vieths S, Scheurer S: Mutational epitope analysis of Pru av 1 and Api g 1, the major allergens of cherry (Prunus avium) and celery (Apium graveolens): correlating IgE reactivity with three-dimensional structure. Biochem J 2003;376:97–107.
47.
Wiche R, Gubesch M, Konig H, Fotisch K, Hoffmann A, Wangorsch A, Scheurer S, Vieths S: Molecular basis of pollen-related food allergy: identification of a second cross-reactive IgE epitope on Pru av 1, the major cherry (Prunus avium) allergen. Biochem J 2005;385:319–327.
48.
Vrtala S, Hirtenlehner K, Susani M, Akdis M, Kussebi F, Akdis CA, Blaser K, Hufnagl P, Binder BR, Politou A, Pastore A, Vangelista L, Sperr WR, Semper H, Valent P, Ebner C, Kraft D, Valenta R: Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J 2001;15:2045–2047.
49.
Crameri R: Correlating IgE reactivity with three-dimensional structure. Biochem J 2003;376:e1–e2.
50.
Miles S, Bolhaar ST, Gonzalez-Mancebo E, Hafner C, Hoffmann-Sommergruber K, Fernandez-Rivas M, Knulst AC: Attitudes towards low-allergen food in food allergic consumers. Nutr Food Sci 2005;35:220–228.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.